Journal of Comparative Effectiveness Research

Ospemifene versus local estrogen: adherence and costs in postmenopausal dyspareunia.

Indicator of access to medicines in relation to the multiple dimensions of access.

Patients’ early engagement in research proposal development (PEER-PD): patients guiding the proposal writing

Paper and electronic versions of HM-PRO, a novel patient-reported outcome measure for hematology: an equivalence study.

Minimally-invasive surgery for degenerative spondylolisthesis: transforaminal or oblique lumbar interbody fusion.

Cost-effectiveness of elagolix versus leuprolide acetate for treating moderate-to-severe endometriosis pain in the USA.

A cost-utility analysis of dulaglutide versus insulin glargine as third-line therapy for Type 2 diabetes in Canada.

Multi-gene assays: effect on chemotherapy use, toxicity and cost in estrogen receptor-positive early stage breast cancer.

Sickle cell disease and readmissions rates after lower extremity arthroplasty: a multistate analysis 2007-2014.

Patient characteristics and stroke and bleeding events in nonvalvular atrial fibrillation patients treated with apixaban and vitamin K antagonists: a Spanish real-world study.

Clinical and economic outcomes of ProGlide compared with surgical repair of large bore arterial access.

Sexually transmitted infections in privately insured adults with intellectual and developmental disabilities.

Reporting and analyses of sex/gender and race/ethnicity in randomized controlled trials of interventions published in the highest-ranking anesthesiology journals.

Comparative outcome of induced labor by intracervical Foley catheter with misoprostol versus misoprostol alone.

Comparative effectiveness of a human fibroblast-derived dermal substitute and a viable cryopreserved placental membrane for the treatment of diabetic foot ulcers.

Osimertinib in first-line treatment of advanced EGFR-mutated non-small-cell lung cancer: a cost-effectiveness analysis.

Cost minimization analysis of catheter ablation for paroxysmal atrial fibrillation by catheter technology.

Mental state, psychoemotional status, quality of life and treatment compliance in patients with Type 2 diabetes mellitus.

Comparative clinical effects and cost-effectiveness of maximum androgen blockade, docetaxel with androgen deprivation therapy and ADT alone for the treatment of mHSPC in China.

Comparison between oral and intravenous application of tranexamic acid for total hip arthroplasty: a meta-analysis.

Efficiency of acute public hospitals in the region of Murcia, Spain.

Ability to pay for medication: a clustering analysis of 1404 patients with the Patient Financial Eligibility Tool.

Comparative and combined effectiveness of innovative therapies in cancer: a literature review.

Complications in type III open tibial shaft fractures treated with open reduction and internal fixation.

Ceftriaxone versus ampicillin/sulbactam for the treatment of aspiration-associated pneumonia in adults.

Is routine baseline brain imaging needed for all newly diagnosed non-small-cell lung cancer patients?

Incremental direct healthcare expenditures of valvular heart disease in the USA.

Does evidence matter? Comparative effectiveness research and prescribing of Type 2 diabetes mellitus drugs.

How different is research done by the Patient-centered Outcomes Research Institute, and what difference does it make?

Intravenous tranexamic acid reduces blood transfusions in revision total hip arthroplasty: a meta-analysis.

Policy perspectives on alternative models for pharmaceutical rebates: a report from the Institute for Clinical and Economic Review Policy Summit.

Positive deviance approaches to improving vaccination coverage rates within healthcare systems: a systematic review.

Systematic review of societal costs associated with stroke, bleeding and monitoring in atrial fibrillation.

Using flowable gelatin in anterior cervical spine surgery in real-world practice: a retrospective cohort study.

Factors associated with evidence-based decision-making among patients and providers.

Engaging parent-child dyad and healthcare provider stakeholders in a patient-centered comparative effectiveness study.

Complications and associated healthcare costs of transvenous cardiac pacemakers in Germany.

Factors related to the comparative effectiveness of clozapine in patients with schizophrenia.

Cost-effectiveness of tacrolimus for the treatment of moderate-to-severe lupus nephritis in China.

Putting patients first: an inventive service delivering cancer treatment at home.

Costs, exacerbations and pneumonia after initiating combination tiotropium olodaterol versus triple therapy for chronic obstructive pulmonary disease.

Twelve-month healthcare utilization and expenditures in Medicare fee-for-service patients with clinically significant mitral regurgitation.

Improving the quality of economic evaluation in health in low- and middle-income countries: where are we now?

Cost minimization comparison of oral UFT/leucovorin versus 5-fluorouracil/leucovorin as adjuvant therapy for colorectal cancer in Taiwan.

Gelatin tannate versus other antidiarrheal medication in children with acute gastroenteritis: a retrospective, observational study.

Treatment patterns and costs among biologic-naive patients initiating apremilast or biologics for psoriatic arthritis.

Facilitators and barriers to successful recruitment into a large comparative effectiveness trial: a qualitative study.